No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

scientific article published in April 1996

No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/GENO.1996.0158
P698PubMed publication ID8617509

P50authorLindsay A. FarrerQ37380266
John GrowdonQ67217951
Jonathan L HainesQ73570557
James F. GusellaQ1602688
P2093author name stringM A Pericak-Vance
A D Roses
G W Small
P M Conneally
P C Gaskell
S A Auerbach
A M Saunders
J M Schildkraut
P A Locke
B L Rosi
L Yamaoka
M L Pritchard
P433issue1
P304page(s)53-56
P577publication date1996-04-01
P1433published inGenomicsQ5533503
P1476titleNo genetic effect of alpha1-antichymotrypsin in Alzheimer disease.
P478volume33

Reverse relations

cites work (P2860)
Q53216211Absence of the A1252G mutation in alpha 1-antichymotrypsin in a North American population suffering from dementia.
Q35091381Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease
Q53328886Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.
Q53220741Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.
Q34208401Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease
Q53230050Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.
Q53247598Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.
Q53095034Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis.
Q73540046Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland
Q33714955Clinical rationale of genetic testing in dementia
Q28578893Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease
Q35882298Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4
Q53329766Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene.
Q33588353Genetic risk factors in Alzheimer's disease
Q53222439Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE.
Q37610265Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions
Q36607337Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies
Q58451980Implication of α1-antichymotrypsin polymorphism in familial Alzheimer's disease
Q41712475Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator
Q73327181Lack of association between alpha1-antichymotrypsin polymorphism and late-onset depressive disorder
Q33842568Molecular genetics of Alzheimer's disease.
Q35821959Molecular genetics of late-onset Alzheimer's disease.
Q35009772Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease
Q53215696No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.
Q73655866No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease
Q47712672No association of alpha1-antichymotrypsin flanking region polymorphism and Alzheimer disease risk in early- and late-onset Alzheimer disease patients
Q33760959Progress toward valid transgenic mouse models for Alzheimer's disease
Q34108351The genetics of Alzheimer's disease
Q73745521The genetics of Alzheimer's disease

Search more.